Leaflet VENTURAX 20mg / 5mg / ml ophthalmic drops solution
Indicated for: glaucoma; ocular hypertension
Route of administration: ophthalmic
Substance: dorzolamide + timolol (glaucoma agent + beta blocker)
ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Older people may have an increased risk of side effects.
The combination of Dorzolamide + timolol is used for the treatment of glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Dorzolamide is a carbonic anhydrase inhibitor, and Timolol is a beta-blocker; together, they reduce intraocular pressure through complementary mechanisms.
The medication is available as eye drops and is usually administered twice daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.
Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, fatigue, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the administration instructions to ensure treatment effectiveness.
General data about VENTURAX 20mg / 5mg / ml
- Substance: dorzolamide + timolol
- Date of latest medicines list: 01-07-2013
- Product code: W57916001
- Concentration: 20mg / 5mg / ml
- Pharmaceutical form: ophthalmic drops solution
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.